Integrating cheminformatic analysis in combinatorial chemistry.
暂无分享,去创建一个
[1] George M. Milne,et al. Chapter 35. Pharmaceutical productivity — the imperative for new paradigms , 2003 .
[2] Steven L. Teig,et al. Luddite: An Information-Theoretic Library Design Tool , 2003, J. Chem. Inf. Comput. Sci..
[3] Eric A Jamois,et al. Reagent-based and product-based computational approaches in library design. , 2003, Current opinion in chemical biology.
[4] Y. Martin. Diverse viewpoints on computational aspects of molecular diversity. , 2001, Journal of combinatorial chemistry.
[5] J. Blake. Examination of the computed molecular properties of compounds selected for clinical development. , 2003, BioTechniques.
[6] Ian A. Watson,et al. Characteristic physical properties and structural fragments of marketed oral drugs. , 2004, Journal of medicinal chemistry.
[7] Tudor I. Oprea. Current trends in lead discovery: Are we looking for the appropriate properties? , 2002, J. Comput. Aided Mol. Des..
[8] Todd J. A. Ewing,et al. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..
[9] Trudi Wright,et al. Optimizing the Size and Configuration of Combinatorial Libraries , 2003, J. Chem. Inf. Comput. Sci..
[10] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[11] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[12] R. Spencer,et al. High-throughput screening of historic collections: observations on file size, biological targets, and file diversity. , 1998, Biotechnology and bioengineering.
[13] Wolfgang H. B. Sauer,et al. Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..
[14] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[15] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[16] Daniel C. Weaver. Applying data mining techniques to library design, lead generation and lead optimization. , 2004, Current opinion in chemical biology.
[17] J. Proudfoot. Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. , 2002, Bioorganic & medicinal chemistry letters.
[18] James F Blake,et al. Structure-based generation of viable leads from small combinatorial libraries. , 2004, Current opinion in drug discovery & development.
[19] Robert D. Clark,et al. OptDesign: Extending Optimizable k-Dissimilarity Selection to Combinatorial Library Design , 2003, J. Chem. Inf. Comput. Sci..
[20] S. Venkatesh,et al. Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.
[21] E. Bradley,et al. Comparing performance of computational tools for combinatorial library design. , 2003, Journal of medicinal chemistry.
[22] A. Stevens,et al. Computational design strategies for combinatorial libraries. , 2003, Current opinion in chemical biology.
[23] P. Leeson,et al. A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.
[24] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[25] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[26] Ellen R. Laird,et al. Chppter 30. Recent advances in virtual ligand screening , 2003 .
[27] Fei Gu,et al. Design of Diverse and Focused Combinatorial Libraries Using an Alternating Algorithm , 2003, J. Chem. Inf. Comput. Sci..
[28] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[29] Roland E Dolle,et al. Comprehensive survey of combinatorial library synthesis: 2002. , 2003, Journal of combinatorial chemistry.
[30] E. Bradley,et al. Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists. , 2003, Journal of medicinal chemistry.